Brief: Myriad Genetics Expects Q3 Revenue About $210 Million-$212 Million
09/10/2024 12:05
Myriad Genetics Inc MYGN.O :
* MYRIAD GENETICS: EXPECTS Q3 REVENUE ABOUT $210
MILLION-$212
MILLION
* : REAFFIRMS FULL-YEAR 2024 REVENUE GUIDANCE OF $835M-$845M
* Q3 REVENUE VIEW $209.4 MILLION -- LSEG IBES DATA
* FY2024 REVENUE VIEW $840.8 MILLION -- LSEG IBES DATA
Source text for Eikon: ID:n0000899923-24-000048
Further company coverage: MYGN.O
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple